Diagnosis and management of gastrointestinal complications in adult cancer patients: 2017 updated evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)

被引：0
作者：
M. Schmidt-Hieber
J. Bierwirth
D. Buchheidt
O. A. Cornely
M. Hentrich
G. Maschmeyer
E. Schalk
J. J. Vehreschild
Maria J. G. T. Vehreschild
机构：
[1] HELIOS Klinikum Berlin-Buch,Clinic for Hematology, Oncology, Tumor Immunology and Palliative Care
[2] BZH GmbH,Deutsches Beratungszentrum für Hygiene
[3] University of Heidelberg,3rd Department of Internal Medicine
[4] University of Cologne, Hematology and Oncology
[5] German Center for Infection Research (DZIF), Mannheim University Hospital
[6] partner site Bonn-Cologne,1st Department of Internal Medicine
[7] University of Cologne,Clinical Trials Centre Cologne, ZKS Köln
[8] Rotkreuzklinikum München,Department III for Internal Medicine, Hematology and Oncology
[9] Ernst-von-Bergmann Klinikum,Department of Hematology, Oncology and Palliative Care
[10] Otto-von-Guericke University,Department of Hematology and Oncology, Medical Center
[11] Hospital of the University of Cologne,1st Department of Internal Medicine
来源：
Annals of Hematology | 2018年 / 97卷
关键词：
Abdominal complications; Colitis; Diarrhea; Chemotherapy; Cancer; Infection;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Cancer patients frequently suffer from gastrointestinal complications. In this manuscript, we update our 2013 guideline on the diagnosis and management of gastrointestinal complications in adult cancer patients by the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). An expert group was put together by the AGIHO to update the existing guideline. For each sub-topic, a literature search was performed in PubMed, Medline, and Cochrane databases, and strengths of recommendation and the quality of the published evidence for major therapeutic strategies were categorized using the 2015 European Society for Clinical Microbiology and Infectious Diseases (ESCMID) criteria. Final recommendations were approved by the AGIHO plenary conference. Recommendations were made with respect to non-infectious and infectious gastrointestinal complications. Strengths of recommendation and levels of evidence are presented. A multidisciplinary approach to the diagnosis and management of gastrointestinal complications in cancer patients is mandatory. Evidence-based recommendations are provided in this updated guideline.
引用
收藏
页码：31 / 49
页数：18
相关论文
共 1022 条
[1]  
Vehreschild MJ(2013)Diagnosis and management of gastrointestinal complications in adult cancer patients: evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO) Ann Oncol 24 1189-1202
[2]  
Vehreschild JJ(2014)European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Fungal Infection Study Group (EFISG) and European Confederation of Medical Mycology (ECMM) 2013 joint guidelines on diagnosis and management of rare and emerging fungal diseases Clin Microbiol Infect 20 1-4
[3]  
Hubel K(2017)2016 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following multiple-day chemotherapy, high-dose chemotherapy, and breakthrough nausea and vomiting Support Care Cancer 25 303-308
[4]  
Hentrich M(2007)Work-up for infectious diarrhea after allogeneic hematopoietic stem cell transplantation: single specimen testing results in cost savings without compromising diagnostic yield Transpl Infect Dis 9 265-269
[5]  
Schmidt-Hieber M(2016)European Society of Clinical Microbiology and Infectious Diseases: update of the diagnostic guidance document for Clostridium difficile infection Clin Microbiol Infect 22 S63-S81
[6]  
Christopeit M(2008)Multimodality management of a polyfunctional pancreatic endocrine carcinoma with markedly elevated serum vasoactive intestinal polypeptide and calcitonin levels Pancreas 36 309-313
[7]  
Cornely OA(1956)Studies on tryptophan and serotonin in patients with malignant carcinoid Science 123 669-445
[8]  
Cuenca-Estrella M(1996)Paraneoplastic spastic tetraparesis in glucagonoma syndrome. Successful therapy with octreotide, dacarbazine and interferon-alpha Z Gastroenterol 34 438-247
[9]  
Meis JF(1986)Long survival of diarrhea-associated hepatocarcinoma treated with Adriamycin and indomethacin. A case report Am J Clin Pathol 86 241-263
[10]  
Ullmann AJ(1980)The glucagonoma syndrome. Report of a case Arch Intern Med 140 262-883
12345678910